Heart health

Every post on heart health, newest first.

Posts

StudiesOct 27, 20264 min read
Liraglutide studies weigh heart rhythm, bone, and antipsychotic weight
Three new reports look at liraglutide from different angles. They find fewer irregular heartbeats in one group, weight loss in people taking antipsychotics, and thin evidence on bone.

Compound pages

The evergreen research summaries these posts build on.

LiraglutideA once-daily GLP-1 injection approved for weight loss and diabetes.DulaglutideOnce-weekly GLP-1 agonist for type 2 diabetes and heart-risk reduction.ExenatideA GLP-1 receptor agonist studied for diabetes and weight.CagrilintideOnce-weekly investigational amylin analogue for weight management.